Interm Results Upadate

The Board of Sutherland Health Group announces that the business for the six months to 30th September 2009 has shown continued growth.

                                                                                                                                          11 November 2009

                                                          SUTHERLAND HEALTH GROUP PLC
                                              ("Sutherland Health Group" or "the Company")
                                                                  PLUS Symbol: SHGP

Interim results update and SHG delivers a maiden interim profit

The Board of Sutherland Health Group, a national supplier of patient hygiene and sexual health products to customers including the NHS, announces that the business for the six months to 30th September 2009 has shown continued growth. The full interim results for the period will be announced on Monday 16th
November 2009.

Reported sales in the period were £469,089 (2008: £409,850), up 14% on the same period last year.

Gross Profit rose by 20% to £240,383 (2008: £200,206)

The Company is also pleased to announce that it has made a maiden interim profit during the period of £7,245 (2008: Loss of £57,821)

Commenting on the news Chairman John French said:

"I am delighted to report that we have reached the important milestone of delivering a maiden interim profit. The Company has shown consistent growth in customers and in their interest in the range of products that we have developed. We look forward to updating shareholders on further new developments that should see our current growth trend continue"

The Directors of the Issuer accept responsibility for this announcement.


Sutherland Health Group plc
John French, Chairman
T: 07836 722 482

Bridge Hall Stockbrokers Limited
Alex Benger
T: 020 7337 9705

Bishopsgate Communications Ltd.
Maxine Barnes
T: 020 7562 3367

Notes to Editors:
Sutherland Health Group Plc is a national supplier of patient hygiene, sexual health and diagnostic products to the UK National Health Service (NHS) and other UK customers. Its aim is to supply innovative solutions to current health issues by studying current trends and working alongside leading professionals
who also work within the health sector.

The company is committed to developing and marketing high quality brands and products that will benefit health professionals and consumers alike in many areas of health. The Group has established its own brands Condomania® Condoms, Sutherland® Lubricating Jelly and Vision® pregnancy diagnostics that have already become established within the NHS business.

The Company has also developed the Sutherland® patient hygiene range which is now on contract with NHS England and NHS Northern Ireland that can reduce the risk to patients of cross infection.

The Group is ISO and MHRA registered, and at present principally operates within the United Kingdom.

For further information on the Company visit


Latest news RSS


Sutherland at Procurex Wales 2017

Sutherland at Procurex Wales 2017


Final Results 30th September 2016

Sutherland Health Group Final Results September 2016


Sutherland Attending European Midwives Conference

Sutherland Attending EMA Conference

Sign up


For further information, please read our Privacy Policy.